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Abstract
The association between the wnt signaling pathway and apoptosis has become more firmly established in the recent 
scientific literature. Many reports indicate that the wnt signaling pathway regulates apoptosis through a variety of 
mechanisms.
The activity of wnt signaling according to specific cellular environment stimuli can either foster or restrain the 
processes of apoptosis. Wnt signaling regulates the early and late stages of apoptosis in both development and cellular 
injury in populations of neurons, endothelial cells, vascular smooth muscle cells and cardiomyocytes.
In this review I draw attention to genes and proteins of the wnt signaling pathway involved in apoptosis and describe 
some of their functional effects.
Introduction
The process of apoptosis has a critical role for the sur-
vival of an organism and is functionally conserved in all
higher eukaryotes, while the disregulation of apoptosis
has been implicated in many different diseases. Impair-
ment of normal apoptosis can lead to cancer or autoim-
mune disease [1], while too much apoptosis causes
neurodegenerative and neuromuscular disease where
progressive loss of neurons occurs due to apoptosis [1-3].
Association between the wnt signaling pathway and
apoptosis has become increasingly established through
recent reports in the literature. Genes in both the apop-
totic and wnt pathways are activated in a successive coor-
dinated fashion throughout embryonic development.
Wnt signaling is essential in development because it acts
as a regulator of the embryonic cell patterning, prolifera-
tion, differentiation, cell adhesion, cell survival and apop-
tosis. It is especially important in the development of the
central nervous system because processes that include
synaptic rearrangements require the expression of molec-
ular components of the wnt pathway [4]. The pathway
regulates the normal development of the neural plate and
neural tube, and later of the brain, spinal cord, and
numerous sensory and motor neurons [5-7]. In addition
to neural tissues, wnt pathway is also critical for sound
vascular and cardiac systems development [8]. Further-
more, wnt signaling modulates most aspects of osteoblast
physiology, including bone cell apoptosis [9].
The mechanisms of apoptosis have proven to be crucial
for homeostasis maintenance of tissues and organisms.
When considering the broader picture of apoptosis, this
biological phenomenon can today be interpreted in the
new light as a basic mechanism in the life-preserving
activities of an organism.
Molecular key players involved in apoptosis
In mammals, two distinct apoptotic pathways exist that
both end in caspase activation. The first is called the
"death receptor pathway", which is initiated by extracellu-
lar ligands such as TNFalpha, or FasL (Fas ligand)/
CD95L, TWEAK and TRAIL; these bind to their respec-
tive receptors on the cellular surface, TNFR, Fas/CD95,
DR3, DR4/DR5.
The death receptor pathway of Fas ligand and Fas
receptor signaling in Figure 1 has been chosen as an
example, since it represents the classical apoptotic path-
way activated by extrinsic signals [10]. The proteins of the
Fas ligand and Fas receptor (Fas or FasR) both act at the
cytoplasmic membrane. Fas is a transmembrane protein
that acts as a cell surface receptor related to the receptor,
TNFR (Tumor Necrosis Factor receptor), whereas FasL is
related to TNF. We have to keep in mind that the induc-
tion of apoptosis via death receptors is extremely fast, the
ligands activating caspases within seconds of being
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bound to the receptor. The consequence of death ligand
binding on the Fas receptor is the trimerization of recep-
tors, which amplifies the apoptotic signal required for full
triggering of the apoptotic response. Following ligand
binding, a conformational change in the intracellular
domain of the receptors reveals the presence of a specific
domain called the "death domain" (DD). After the activa-
tion, the receptors recruit to their cytoplasmic face adap-
tor proteins such as FADD or TRADD. The initiator
caspase-8 binds to the adaptor molecule, precisely to the
"death effector domain" (DED), resulting in the formation
of a casposome. The casposome is often called the
"death-inducing signaling complex" (DISC) [2,3].
The second pathway of apoptotic signaling is under the
control of the Bcl-2 (B-cell lymphoma 2) family of genes
and its proteins. It is initiated by intrinsic signals trans-
mitted via intracellular molecular components that also
ultimately lead to caspase activation. Our knowledge on
how this signal is transmitted is still rudimentary, but we
do know that the outer membrane of mitochondria gets
directly perforated as a result [1]. The complex nature of
higher eukaryotes, and especially mammals, conditioned
the evolution of Bcl-2 protein families with numerous
members. They can be categorized as those that promote
cellular survival and those that act pro-apoptotically to
induce programmed cell death. More accurately, the Bcl-
2 proteins should be classified into 3 categories. Proteins
that promote cellular survival, i.e. anti-apoptotic proteins,
belong to the first category. They are called Bcl-2-like
survival factors and include Bcl-2, Bcl-xL, Bcl-w/Bcl2L2,
Mcl-1, Bcl2A1/Bfl-1, NR-13, Boo/Diva/Bcl2-L-10 and
Bcl-B, being similar to CD-9 in C. elegans. The second
group is called BH3-only death factors; they act pro-
apoptotically and are similar to EGL-1 in C. elegans. BH3-
only death factors are Bik/Nbk, Blk, Hrk/DP5, BNIP3,
Bcl2L11/BimL/Bod, Bad, Bid, PMAIP1/Noxa, PUMA/
Bbc3 and Bmf. All members of this group possess only a
specific BH3 domain, a short domain consisting of 9-16
amino acids [11]. It is now believed that BH3-only pro-
teins are the essential initiators of apoptosis.
The third category of Bcl-2 proteins is also pro-apop-
totic and some scientists call them Bax-like death factors.
The proteins from this group are not present in C. ele-
gans. Bax, Bak, Bok/Mtd, Bcl-xs and Drosophila DEBCL
gene belong to Bax-like death factors [2]. When apoptotic
signal occurs, BH3-only proteins become active because,
inter alia, of transcription induced by the transcription
factor, p53. PUMA and Noxa are BH3-only proteins
induced by p53. PUMA accounts for all the proapoptotic
activity of p53 [12].
Human Bcl-2 genes are dispersed across the human
genome and are not clustered at specific loci (Table 1).
The role of mitochondria in apoptosis is remarkable;
they contain many pro-apoptotic signals of which the
most important are: AIF (apoptosis inducing factor),
Smac, DIABLO and definitely cytochrome C. Formation
of specific mitochondrial membrane pores occurs
through the action of apoptosis promoting members of
the Bcl-2 protein family. These pores are called "permea-
bility transition pores" (PT). Once the PT pores are
formed, pro-apoptotic molecules - AIF, Smac, DIABLO
and cytochrome C - exit the mitochondrion. The release
of cytochrome C into the cytosol is especially significant
event for the induction of apoptosis. Cytochrome C inter-
acts with a protein called Apaf (the homologue of CED-4
in C. elegans), which in turns activates caspase-9 and later
caspase-3. The multiprotein complex casposome (apop-
tosome) forms, conprising cytochrome C, A paf-1, pro-
caspase-9 and ATP [1] (Figure 2).
Wnt signal transduction pathway and apoptosis
I will briefly describe the mechanisms of classical wnt sig-
naling. The wnt/wingless pathway was first discovered in
Drosophila and mouse, and is one of the most interesting
signal transductions, in which key components have mul-
tiple functions. In vertebrate cells, it is named after wnt
proteins, a family of highly conserved secreted signaling
molecules [8]. Insights into the mechanisms of wnt action
have emerged from several systems: genetics in Droso-
phila  and  C. elegans; biochemistry in cell culture; and
ectopic gene expression in Xenopus embryos. Many wnt
genes in the mouse have been mutated, leading to highly
specific developmental defects. As currently understood,
wnt proteins bind to receptors of the Frizzled family on
the cell surface. Through several cytoplasmic relay com-
ponents, the signal is transduced to β-catenin, which
enters the nucleus to activate transcription of wnt target
Figure 1 Death receptor pathway via Fas ligand and Fas receptor. 
DD - the specific "death domain"; DISC- death-inducing signaling com-
plex (From: Pećina-Šlaus N. Acta Medica Croatica. Supplement., 63 
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genes. Although the main signaling molecule of the path-
way is β-catenin, APC is a critical component in the for-
mation of multiprotein complex with axin/axin2, casein
kinase I and glycogen synthase kinase 3-β (GSK3-β).
Beta-catenin is recruited to this complex, phosphory-
lated, ubiquitinated and consequently heads to the pro-
teasome. When wnt ligand is absent, β-catenin is
constantly being destroyed. In response to wnt signaling,
or under the circumstances of mutated APC, β-catenin is
stabilized, accumulates in the cytoplasm and enters the
nucleus, where it finds a partner, a member of the DNA
binding protein family, the lymphoid enhancer factor-T
cell factor (LEF/TCF). Together they activate the tran-
scription programs of target genes, such as c-MYC and
cyclin D1, explaining why constitutive activation of the
wnt pathway can lead to cancer.
It has been well documented that wnt genes and other
components of wnt signaling are critical for mammalian
embryogenesis [8,9]. Furthermore, malfunctioning of this
pathway in adult organism is responsible for tumorigene-
sis in many different tissues.
The activity of wnt signaling according to specific cellu-
lar environment stimuli can either foster or restrain the
processes of apoptosis [13,14]. Wnt signaling regulates
the early and late stages of apoptosis in both development
and cellular injury in the cell populations of neurons,
endothelial cells, vascular smooth muscle cells and cardi-
omyocytes [8].
Many reports indicate that the wnt signaling pathway
regulates apoptosis through a variety of mechanisms. The
most important mechanisms include those through wnt-
BMP signaling, through SFRP2 (secreted Frizzled-related
protein-2) gene expression, through β-catenin, GSK 3-β-
NF-κBeta, c-Jun N-terminal kinase signaling, or gene
expression of Dickkopf-1, nemo, sox 10 and tau [8,15,16].
Very interesting and novel are the data on the tumor
suppressor protein, adenomatous polyposis coli (APC),
and its role in apoptosis [14,17,18]. The gene encodes a
large multidomain 2843 amino acid protein that is
expressed in a number of fetal and adult human tissues.
The wild type protein of ~310 kDa has multiple func-
tional domains. APC is illustrative of the multiple roles
that certain tumor suppressors play in a cell. The protein
of this tumor suppressor gene has many cellular func-
tions: as a component of the wnt signal transduction
pathway, of adherens junctions, and the mechanism of
cytoskeleton stabilization. Mutation analysis of the APC
gene revealed over 400 different germline mutations
responsible for familial adenomatous polyposis coli
(FAP), but the overall number of detected mutations, ger-
mline and somatic [19] exceeds 700 according to the
Human Gene Mutation Database [HGMD, http://
www.hgmd.org]. The majority of detected mutations
result in a truncated (shorter) protein product. The
majority of cancer mutations occur in the mutation clus-
ter region (MCR) located within exon 15, introducing
premature stop codons. Multiple truncated proteins lack-
ing C-terminal end are produced in such a fashion. APC's
role in apoptosis regulation is dependent on whether it is
comprised of full length (wild type) or truncated (mutant)
proteins. Overexpression of wild type APC (310 kDa)
induces apoptosis, while overexpression of mutant trun-
cated proteins maintains an anti-apoptotic mode of
action. Brocardo and Henderson [14] have recently iden-
tified APC at mitochondria and noticed that the strongest
accumulation is this protein's shorter truncated polypep-
tide sequences. Mitochondrial localization of the endoge-
nous APC mutants with sequence 1-1309 correlated with
tumor cell survival, i.e. reduced apoptosis. Parallel find-
ings indicated that overexpressed APC mutant proteins
Table 1: Chromosomal distribution of the Bcl-2 family members in the human genome.
Survival factors Bax-like death factors BH3 domain only death factors
GENE LOCUS GENE LOCUS GENE LOCUS GENE LOCUS
Bcl-2 18q21.33 Bak 6p21.31 Bad 11q13.1 Hrk 12q24.22
Bcl2A1 (Bfl-1) 15q25.1 Bax 19q13.33 Bcl2L11(BimL/Bod) 2q13 PMAIP1 (Noxa) 18q21.32
Bcl2-L-10(Boo/DIVA) 15q21.2 Bcl-xs 20q11.21 Bid 22q11.21 PUMA 19q13.32
Bcl2L2 (Bcl-w) 14q11.2 Bok 2q37.3 Bik 22q13.2 BNIP3 10q26.3
Bcl-xL 20q11.21 Blk 8p23.1
Mcl-1 1q21.2 Bmf 15q15.1Pe(ina-Šlaus Cancer Cell International 2010, 10:22
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can bind to Bcl-2 proteins and increase their levels in
mitochondria. It is still not clear how truncated APC pro-
teins promote survival. APC mutants are extremely
mobile and one possible explanation is that they relocate
Bcl-2 from other cellular places to mitochondria. Such an
increase of the amount of Bcl-2 survival factors might
explain the continued survival and proliferation of cancer
cells.
One of the best researched wnt proteins, protein Wnt1,
has also been associated with the control of apoptotic
processes [20]. Wnt-1 can inhibit apoptosis it prevents
the release of cytochrome C from mitochondrion, and
successively inhibits the activity of caspase-9 [8,14].
Additional research has demonstrated that wnt signaling
can restrain the process of apoptosis and increase sur-
vival by activating NF-κβ or inhibiting GSK3-β. GSK3-β
knockout mice die in utero from apoptosis of hepato-
cytes, while cells that lack GSK3-β genes have very low
levels of NF-κβ, indicating that GSK3-β function is
required for the NF-κβ-mediated survival.
Conclusions and future perspectives
Programmed cell death plays a major physiological role in
multicellular organism development and maintenance of
homeostasis. Pro-and anti-apoptotic mechanisms repre-
sent exceptional potential targets for disease treatment.
Therapeutics that promote cell survival by restraining
apoptotic processed, as well as those that could enhance
apoptosis, offer opportunities for the intelligent design of
future therapeutic drugs. Restoring apoptotic activity can
be a promising approach to inducing death of autoim-
mune and cancer cells, while therapies that arrest apopto-
sis in neuronal degradation would reduce neurodegener-
ative and neuromuscular disease.
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